P. Peter Ghoroghchian

Biography

  Dr. Ghoroghchian is the Charles W. and Jennifer C. Johnson Clinical Investigator in the Koch Institute for Integrative Cancer Research at MIT as well as an Attending Physician at the Dana-Farber Cancer Institute. He earned his B.S. in chemical engineering from MIT in 1999, followed by Ph.D. (2006) and M.D. (2008) degrees from the University of Pennsylvania. After medical school, Dr. Ghoroghchian completed internship and residency training in Internal Medicine at the Brigham and Women’s Hospital, as well as fellowship training in hematology and medical oncology at the Dana-Farber/Partners CancerCare. In 2014, he joined the staff of Dana-Farber and Brigham and Women's Hospital, where he is a medical oncologist and research investigator in the Gynecologic Oncology Program. At MIT, Dr. Ghoroghchian’s research group focuses on the rational design of materials for ovarian cancer diagnosis, accelerated therapeutic discovery, and targeted drug delivery. His investigations are further informed by his experience in the biotechnology industry; a co-founder and chief scientist at Vindico NanoBioTechnology, Inc. Dr. Ghoroghchian has also overseen research efforts at PhenoTech, Inc., and other firms.

Research Interest

  Ovarian cancer, Novel therapies